Back
Movano, Inc. 10K Form
Buy
53
MOVE
Movano, Inc.
Last Price:
$8.91
Seasonality Move:
-17.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-17 | 10Q | MOVE/Movano, Inc. Quarterly |
| 2023-11-14 | 10Q | MOVE/Movano, Inc. Quarterly |
| 2023-08-14 | 10Q | MOVE/Movano, Inc. Quarterly |
| 2023-05-15 | 10Q | MOVE/Movano, Inc. Quarterly |
| 2022-11-14 | 10Q | MOVE/Movano, Inc. Quarterly |
| 2022-08-15 | 10Q | MOVE/Movano, Inc. Quarterly |
Receive MOVE News And Ratings
See the #1 stock for the next 7 days that we like better than MOVE
MOVE Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-1.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.04 |
| Price / Book: | 5.46 |
Profitability
| EPS (TTM): | -22.88930 |
|---|---|
| Net Income (TTM): | $-17M |
| Gross Margin: | $-2.1M |
| Return on Equity: | -410.28% |
| Return on Assets: | -187.88% |
Movano, Inc. Earnings Forecast
Key Movano, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for MOVE is -206.71%.
-
The Selling, General & Administrative Expenses for MOVE have been equal to 1,089.14% of Gross Profit Margin.
-
The Research & Development expenses have been 1,095.26% of Revenue.
-
The Net Earning history of MOVE is -2,342.25% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 6 years.
Movano, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Technology Hardware, Storage & Peripherals |
| Sector: | Information Technology |
| Current Symbol: | MOVE |
| Website: | movano.com |
Debt
| Debt-to-Equity Ratio: | -1.89 |
|---|---|
| Current Ratio: | 0.7 |
| Quick Ratio: | 0.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MOVE Technical Analysis vs Fundamental Analysis
Buy
53
Movano, Inc. (MOVE)
is a Buy
Is Movano, Inc. a Buy or a Sell?
-
Movano, Inc. stock is rated a BuyThe current Movano, Inc. [MOVE] share price is $8.86. The Score for MOVE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.